Long-Term Cardiac and Pulmonary Complications of Cancer Therapy

被引:2
作者
Yahalom, Joachim [1 ]
Portlock, Carol S. [2 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
关键词
Anthracyclines; Cardiac toxicity; Pulmonary toxicity; Radiotherapy; Taxanes; Trastuzumab; CORONARY-ARTERY-DISEASE; ANTHRACYCLINE-INDUCED CARDIOTOXICITY; HODGKINS-DISEASE; MEDIASTINAL IRRADIATION; BREAST-CANCER; CARDIOVASCULAR-DISEASE; DOXORUBICIN CARDIOTOXICITY; POSTOPERATIVE RADIOTHERAPY; COMPARING DOXORUBICIN; RADIATION-THERAPY;
D O I
10.1016/j.hfc.2011.04.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac complications resulting from chemotherapy and radiation pose a significant risk for morbidity and mortality to the cancer survivor. Cardiac side effects may progress over time and are a concern for patients treated during childhood. Longterm pulmonary complications are relatively infrequent, and acute respiratory effects of drugs (mostly bleomycin) or radiation normally resolve early after therapy. Although most cardiovascular risk statistics and clinical experience are derived from patients treated before 1985, the modern radiation approach that limits the exposure of the heart and reduces the total dose seems to attenuate the previously observed cardiovascular risk. Potential preventive measures for high-risk patients are of increasing interest but remain experimental.
引用
收藏
页码:403 / +
页数:11
相关论文
共 78 条
  • [1] Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy
    Adams, MJ
    Lipsitz, SR
    Colan, SD
    Tarbell, NJ
    Treves, ST
    Diller, L
    Greenbaum, N
    Mauch, P
    Lipshultz, SE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) : 3139 - 3148
  • [2] Radiation-associated cardiovascular disease: Manifestations and management
    Adams, MJ
    Lipshultz, SE
    Schwartz, C
    Fajardo, LF
    Coen, V
    Constine, LS
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2003, 13 (03) : 346 - 356
  • [3] Late cardiotoxicity after treatment for Hodgkin lymphoma
    Aleman, Berthe M. P.
    van den Belt-Dusebout, Alexandra W.
    De Bruin, Marie L.
    van 't Veer, Mars B.
    Baaijens, Margreet H. A.
    de Boers, Jan Paul
    Hart, Augustinus A. M.
    Klokman, Willem J.
    Kuenen, Marianne A.
    Ouwens, Gabey M.
    Bartelink, Harry
    van Leeuwen, Flora E.
    [J]. BLOOD, 2007, 109 (05) : 1878 - 1886
  • [4] AMRONIM GD, 1965, ARCH PATHOL, V75, P219
  • [5] Arbuck S G, 1993, J Natl Cancer Inst Monogr, P117
  • [6] CARDIOVASCULAR SEQUELAE OF THERAPEUTIC THORACIC RADIATION
    ARSENIAN, MA
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1991, 33 (05) : 299 - 312
  • [7] IONIZING RADIATION ATHEROSCLEROSIS AND LIPID METABOLISM IN PIGEONS
    ARTOM, C
    LOFLAND, HB
    CLARKSON, TB
    [J]. RADIATION RESEARCH, 1965, 26 (02) : 165 - &
  • [8] Late cardiac toxicity secondary to treatment in Hodgkin's disease.: A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy
    Avilés, A
    Neri, N
    Nambo, MJ
    Guzman, JH
    Talavera, A
    Cleto, S
    [J]. LEUKEMIA & LYMPHOMA, 2005, 46 (07) : 1023 - 1028
  • [9] Doxorubicin-paclitaxel - A safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European organization for research and treatment of cancer multicenter trial
    Biganzoli, L
    Cufer, T
    Bruning, P
    Coleman, RE
    Duchateau, L
    Rapoport, B
    Nooij, M
    Delhaye, F
    Miles, D
    Sulkes, A
    Hamilton, A
    Piccart, M
    [J]. CANCER, 2003, 97 (01) : 40 - 45
  • [10] BOIVIN JF, 1992, CANCER, V69, P1241